@article {69543,
	title = {Elucidating and Optimizing the Photochemical Mechanism of Coumarin-Caged Tertiary Amines.},
	journal = {J Am Chem Soc},
	year = {2024},
	month = {2024 Jul 18},
	abstract = {<p>Photoactivatable or "caged" pharmacological agents combine the high spatiotemporal specificity of light application with the molecular specificity of drugs. A key factor in all optopharmacology experiments is the mechanism of uncaging, which dictates the photochemical quantum yield and determines the byproducts produced by the light-driven chemical reaction. In previous work, we demonstrated that coumarin-based photolabile groups could be used to cage tertiary amine drugs as quaternary ammonium salts. Although stable, water-soluble, and useful for experiments in brain tissue, these first-generation compounds exhibit relatively low uncaging quantum yield (Φ \&lt; 1\%) and release the toxic byproduct formaldehyde upon photolysis. Here, we elucidate the photochemical mechanisms of coumarin-caged tertiary amines and then optimize the major pathway using chemical modification. We discovered that the combination of 3,3-dicarboxyazetidine and bromine substituents shift the mechanism of release to heterolysis, eliminating the formaldehyde byproduct and giving photolabile tertiary amine drugs with Φ \&gt; 20\%-a 35-fold increase in uncaging efficiency. This new "ABC" cage allows synthesis of improved photoactivatable derivatives of escitalopram and nicotine along with a novel caged agonist of the oxytocin receptor.</p>
},
	issn = {1520-5126},
	doi = {10.1021/jacs.4c03092},
	author = {Banala, Sambashiva and Jin, Xiao-Tao and Dilan, Tanya L and Sheu, Shu-Hsien and Clapham, David E and Drenan, Ryan M and Lavis, Luke D}
}
